Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Phase II Trial of Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01579318
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:09.868432+00:00
Published At
2018-01-03T00:00:00+00:00
Record Updated At
2023-05-15
Results Posted At
2018-01-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cutaneous T Cell Lymphomas (CTCL)", "Mycosis Fungoides (MF)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-15"
protocolSection.identificationModule.nctId
"NCT01579318"
protocolSection.identificationModule.officialTitle
"A Multicenter Phase II Trial of Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-01-03"

Study condition terms

  • Cutaneous T Cell Lymphomas (CTCL) (protocolSection.conditionsModule.conditions)
  • Mycosis Fungoides (MF) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.